Association of Helicobacter pylori with mantle cell lymphoma.

被引:0
|
作者
Paglieroni, TG
Schoenman, L
Simon, GE
Kuramoto, IK
MacKenzie, MR
Kailath, JM
Wong-Lee, J
机构
[1] Sacramento Med Fdn Ctr Blood Res, Sacramento, CA USA
[2] Diagnost Pathol Med Grp, Sacramento, CA USA
[3] Sierra Hematol & Oncol, Carmichael, CA USA
[4] Genelabs Diagnost USA Inc, Redwood City, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4784
引用
收藏
页码:244B / 244B
页数:1
相关论文
共 50 条
  • [31] Dendritic cell-based therapy for the treatment of mantle cell lymphoma.
    Munger, CM
    Hentzen, A
    Vose, JM
    Bociek, RG
    Joshi, SS
    BLOOD, 2003, 102 (11) : 106A - 106A
  • [32] Dose dense, high intensity therapy for mantle cell lymphoma.
    Rizzieri, DA
    Gockerman, JP
    Moore, JO
    DeCastro, C
    Long, GD
    Vredenburgh, JJ
    Niedzwiecki, D
    Edwards, J
    Prosnitz, L
    Gasparetto, C
    Morris, A
    Lassiter, M
    Davis, P
    Chao, NJ
    BLOOD, 2001, 98 (11) : 681A - 682A
  • [33] Correlation of cytogenetic abnormalities with clinical presentation in mantle cell lymphoma.
    Onciu, M
    Schlette, E
    Abruzzo, LV
    Medeiros, LJ
    Lai, R
    MODERN PATHOLOGY, 2001, 14 (01) : 174A - 174A
  • [34] TREATMENT OF RELAPSING OR REFRACTORY MANTLE CELL LYMPHOMA. UNICENTRIC STUDY
    Marc, Sorigue
    Juan-Manuel, Sancho
    Lluis, Virgili
    Miriam, Moreno
    Cristina, Motllo
    Gustavo, Tapia
    Susanna, Gassiot
    Alberto, Pineda
    Jose-Luis, Mate
    Laura, Abril
    Monica, Linares
    Clara, Maluquer
    Edurne, Sarrate
    Ana, Triguero
    Neus, Ruiz-Xiville
    Anna, Torrent
    Susana, Vives
    Christelle, Ferra
    Blanca, Xicoy
    Montserrat, Batlle
    Gladys, Ibarra
    Immaculada, Portal
    Jose-Tomas, Navarro
    Evarist, Feliu
    Josep-Maria, Ribera
    HAEMATOLOGICA, 2016, 101 : 207 - 208
  • [35] Natural history and clinical prognosis of in situ mantle cell lymphoma.
    Kubal, Timothy Edward
    Peker, Deniz
    Sagatys, Elizabeth
    Zhang, Ling
    Naghashpour, Mojdeh
    Moscinski, Lynn
    Sotomayor, Eduardo M.
    Sokol, Lubomir
    Bello, Celeste M.
    Cultrera, Jennifer L.
    Chervenick, Paul A.
    Shah, Bijal D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Cladribine plus rituximab for the initial treatment of mantle cell lymphoma.
    Pindyck, T.
    Spurgeon, S. E.
    Okada, C. Y.
    Epner, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Correlation of cytogenetic abnormalities with clinical presentation in mantle cell lymphoma.
    Onciu, M
    Schlette, E
    Abruzzo, LV
    Medeiros, LJ
    Lai, R
    LABORATORY INVESTIGATION, 2001, 81 (01) : 174A - 174A
  • [38] Analysis of nuclear factor kappa B in mantle cell lymphoma.
    Schrader, C
    Klapper, W
    Janssen, D
    Riis, P
    Meusers, P
    Brittinger, G
    Siebmann, JU
    Kneba, M
    Parwaresch, R
    BLOOD, 2005, 106 (11) : 258B - 258B
  • [39] Impact of rituximab on outcome of autologous transplantation for mantle cell lymphoma.
    Naing, A.
    Palmer, J.
    Tsai, N.
    Kogut, N.
    Popplewell, L.
    Rodriguez, R.
    Krishnan, A.
    Nakamura, R.
    Forman, S. J.
    Nademanee, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 435S - 435S
  • [40] p16 gene aberrations in mantle cell lymphoma.
    Cohen, PL
    James, CD
    Kurtin, PJ
    BLOOD, 1997, 90 (10) : 2187 - 2187